Odense University Hospital is the largest and most specialized hospital in Southern Denmark. OUH is both Odense's and Funen's largest single workplace. It has a budget of 835 million Euro and has 11.000 employees.

There are 1,038 beds in Odense University Hospital.

During the past decade, Odense University Hospital conducted 338 clinical trials. In the 10-year time frame, 338 clinical trials started and 38 clinical trials were completed, i.e. on average, 11.2% percent of trials that started reached the finish line to date. In the past 5 years, 157 clinical trials started and 30 clinical trials were completed. i.e. 19.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Odense University Hospital" #1 sponsor was "Odense University Hospital" with 119 trials, followed by "University of Southern Denmark" with 38 trials sponsored, "Rigshospitalet, Denmark" with 21 trials sponsored, "University of Aarhus" with 11 trials sponsored and "Aarhus University Hospital Skejby" with 11 trials sponsored. Other sponsors include 281 different institutions and companies that sponsored additional 204 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Odense University Hospital" #1 collaborator was "Odense University Hospital" with 96 trials as a collaborator, "Aarhus University Hospital" with 47 trials as a collaborator, "Aalborg University Hospital" with 40 trials as a collaborator, "University of Southern Denmark" with 33 trials as a collaborator and "Rigshospitalet, Denmark" with 30 trials as a collaborator. Other collaborators include 724 different institutions and companies that were collaborators in the rest 406 trials.

According to Clinical.Site data, the most researched conditions in "Odense University Hospital" are "Multiple Myeloma" (18 trials), "Coronary Artery Disease" (15 trials), "Heart Failure" (13 trials), "Breast Cancer" (8 trials) and "Quality of Life" (8 trials). Many other conditions were trialed in "Odense University Hospital" in a lesser frequency.

Most popular intervention types in "Odense University Hospital" are "Drug" (199 trials), "Other" (78 trials), "Device" (66 trials), "Procedure" (63 trials) and "Biological" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "Dexamethasone" (10 trials), "placebo" (7 trials), "Lenalidomide" (6 trials) and "Bortezomib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Odense University Hospital" are 423 trials for "All" genders, 47 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are 189 active trials in "Odense University Hospital". 7 are not yet recruiting, 127 are recruiting, 51 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 227 completed trials in Odense University Hospital, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Odense University Hospital, 21 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 51 trials, and there were also 181 trials that are defined as “Not Applicable".